Valuation : Adocia

Market Cap 80.77M 93.87M 75.79M 69.35M 129M 8.87B 130M 897M 349M 4.53B 353M 345M 14.61B P/E 2026 *
-753x
P/E 2027 * 5.97x
Enterprise Value 50.92M 59.19M 47.79M 43.72M 81.61M 5.59B 82.25M 565M 220M 2.86B 222M 217M 9.21B EV / Sales 2026 *
20.2x
EV / Sales 2027 * 3.13x
Free-Float
96.05%
Yield 2026 *
-
Yield 2027 * -
1 day-1.21%
1 week+2.05%
Current month+2.26%
1 month+1.09%
3 months-1.02%
6 months-37.74%
Current year-39.13%
1 week 3.92
Extreme 3.92
4.17
1 month 3.92
Extreme 3.92
4.3
Current year 3.61
Extreme 3.61
7.45
1 year 3.61
Extreme 3.61
12.4
3 years 2.86
Extreme 2.86
12.66
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
61.9
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 57 -
Director/Board Member 61 11/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/2/25 Buy

Founder

109,170 0.6972%
6/4/24 Buy

Founder

15,576 0.1105%
6/4/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%+2.05%-48.83%-66.19% 93.87M
+0.41%-2.07%+41.26%+95.40% 69.02B
-0.81%+1.01%+43.21%+90.40% 66.32B
+0.04%+4.36%-11.72%+459.54% 27.66B
-0.90%-7.65%+2.45%-15.50% 25.84B
-3.00%-2.90%+39.40%+9.41% 26.54B
0.00%+1.90%+25.90%-17.50% 20.4B
+3.45%-13.46%+222.69%+389.50% 17.63B
-1.49%-4.88%-0.41%+530.26% 15.15B
+1.03%+7.00%+59.98%+160.03% 14.65B
Average -0.26%-0.95%+37.39%+163.54% 28.33B
Weighted average by Cap. -0.28%-0.83%+41.72%+148.33%

Financials

2026 *2027 *
Net sales 2.52M 2.93M 2.37M 2.16M 4.04M 277M 4.07M 27.99M 10.9M 142M 11.01M 10.77M 456M 35.4M 41.14M 33.22M 30.39M 56.73M 3.89B 57.18M 393M 153M 1.99B 155M 151M 6.4B
Net income -4.32M -5.02M -4.05M -3.71M -6.92M -474M -6.97M -47.92M -18.66M -242M -18.84M -18.43M -781M -44.33M -51.52M -41.6M -38.06M -71.03M -4.87B -71.6M -492M -192M -2.49B -193M -189M -8.02B
Net Debt -29.84M -34.69M -28.01M -25.62M -47.82M -3.28B -48.2M -331M -129M -1.68B -130M -127M -5.4B 30.18M 35.07M 28.32M 25.91M 48.36M 3.32B 48.74M 335M 130M 1.69B 132M 129M 5.46B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
04/09/26 EUR 4.078 -1.21% 4,107
03/09/26 EUR 4.128 +0.10% 71,464
02/09/26 EUR 4.124 +2.64% 112,895
01/09/26 EUR 4.018 +0.75% 55,333
31/08/26 EUR 3.988 -0.20% 46,017
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.128EUR
Average target price
9.700EUR
Spread / Average Target
+134.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock